Adriamycin Cancer Drug
The U.S. Food and Drug Administration approved Adriamycin® (doxorubicin hydrochloride) to treat certain types of cancer, namely ovarian, breast, and lung cancers. This drug belongs to the anthracycline class and is given by injection in a healthcare provider's office.
As with any chemotherapy drug for cancer, Adriamycin can cause certain side effects, such as hair loss, nausea, and vomiting. Various factors will affect the dose your healthcare provider recommends, including the type of cancer that is being treated and your height and weight.
(To learn more about this cancer drug, click Adriamycin. Topics discussed in this article include how it works, what to do if you are pregnant or breastfeeding, generic availability, and more.)